Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII). Both had some major announcements to be made in the past month and the stocks have since shown some very positive upside. Veracyte Inc (NASDAQ VCYT) a molecular diagnostics company pioneering…
Here in this article, we take a look at two very promising Biotech stock: Celldex Therapeutics Inc (NASDAQ CLDX) & Dyax Corp (NASDAQ DYAX). Dyax Corp (NASDAQ DYAX) has had the stock price surge after the company made some major announcements in the past couple of months. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is hoping for similar…
In this article, we take a look at two stocks which have been in news recently, Vertex Pharmaceuticals & Ligand Pharmaceuticals. Keep an eye out for Vertex Pharmaceuticals (NASDAQ VRTX) and Ligand Pharmaceuticals (NASDAQ LGND) . Vertex has performed really well in the recent weeks, recording almost a 50% rise in its price levels. Ligand…
Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Abbvie (NYSE ABBV) and MannKind (NASDAQ MNKD). The two stocks have their fortunes at the opposite end of the spectrum. We take a look at what the future holds for the two stocks. Despite three rejections so far, AbbVie is…
Here in this article, we take a look at two very promising stock: Arena Pharmaceuticals (NASDAQ ARNA) & Bristol-Myers Squibb (NYSE BMY). Arena Pharmaceuticals stock (NASDAQ ARNA) has been slightly lukewarm as off late. But that may change with a relaunch on the horizon. Bristol-Myers Squibb have a lot of projects on the horizon which…
In this article, we take a look at two very up and coming stocks in Johnson & Johnson and Sarepta Therapeutics. Keep an eye out for Johnson & Johnson (NYSE JNJ) and Sarepta Therapeutics (NASDAQ SRPT). While at one hand, analysts are optimistic about Johnson & Johnson’s second quarter earnings, Sarepta Therapeutics would be looking…
